Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:2-Dehydro-D-gluconic acid)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteUnits(range)
ST002123 AN003476 GCN2 regulates mitochondrial OXPHOS in HSPCs under proliferation conditions. Bone marrow Mouse Sun Yat-sen University AU
ST001074 AN001756 Open source discovery of starting points for next generation chemoprotective antimalarial drugs (Biofocus 1) Parasite Human Pennsylvania State University Average Peak Area
ST000369 AN000603 Investigation of metabolomic blood biomarkers for detection of adenocarcinoma lung cancer (part II) Blood Human Cancer University of California, Davis Counts
ST000383 AN000618 Plasma Metabolomic Profiles Reflective of Glucose Homeostasis in Non-Diabetic and Type 2 Diabetic Obese African-American Women Blood Human Diabetes University of California, Davis Counts
ST000441 AN000692 Metabolomic Profiling of the Malaria Box Reveals Antimalarial Target Pathways Plasmodium cells Plasmodium falciparum Malaria Pennsylvania State University log2 fold change vs untreated
ST001324 AN002203 Metabolomics Adaptation of Juvenile Pacific Abalone Haliotis discus hannai to Heat Stress Pacific Abalone Institute of Oceanology, Chinese Academy of Sciences mV*s
ST002775 AN004518 Zebrafish Retina Regeneration Metabolomics - 3 Days Post Crush Eye tissue Zebrafish Eye disease University of Miami Normalized Concentrations
ST002009 AN003275 Metabolomics analysis of stress erythroid progenitors Stem cells Mouse Inflammation Pennsylvania State University Normalized peak area
ST002444 AN003982 Zebrafish Optic Nerve Regeneration Metabolomics - 3 Days Post Crush Eye tissue Zebrafish Eye disease University of Miami normalized peak areas
ST002020 AN003290 TIPs Metabolomics (urine) Urine Human Vanderbilt University Medical Center osmolality normalized scaled imputed
ST001985 AN003236 Profiling Plasmodium falciparum parasites and human red blood cells after treatment with MMV693183 Blood Human Malaria Pennsylvania State University Peak Abundance (normalized, blank subtracted, and corrected for baseline noise)
ST001985 AN003236 Profiling Plasmodium falciparum parasites and human red blood cells after treatment with MMV693183 Blood Plasmodium falciparum Malaria Pennsylvania State University Peak Abundance (normalized, blank subtracted, and corrected for baseline noise)
ST001985 AN003236 Profiling Plasmodium falciparum parasites and human red blood cells after treatment with MMV693183 Cultured cells Human Malaria Pennsylvania State University Peak Abundance (normalized, blank subtracted, and corrected for baseline noise)
ST001985 AN003236 Profiling Plasmodium falciparum parasites and human red blood cells after treatment with MMV693183 Cultured cells Plasmodium falciparum Malaria Pennsylvania State University Peak Abundance (normalized, blank subtracted, and corrected for baseline noise)
ST002024 AN003294 Plasmodium falciparum stable-isotope carbon labeling to explore metabolic consequences of keto–acid dehydrogenase disruption Cultured cells Plasmodium falciparum Malaria Pennsylvania State University Peak Abundance (normalized, blank subtracted, and corrected for baseline noise)
ST001990 AN003242 METABOLOMICS OF THE INTERACTION BETWEEN A CONSORTIUM OF ENTOMOPATHOGENIC FUNGI AND THEIR TARGET INSECT: MECHANISMS OF ATTACK AND SURVIVAL. Insect tissue European pepper moth Universidade Federal do Paraná peak area
ST001990 AN003243 METABOLOMICS OF THE INTERACTION BETWEEN A CONSORTIUM OF ENTOMOPATHOGENIC FUNGI AND THEIR TARGET INSECT: MECHANISMS OF ATTACK AND SURVIVAL. Insect tissue European pepper moth Universidade Federal do Paraná peak area
ST002011 AN003277 The anticancer human mTOR inhibitor MLN0128/Sapanisertib with potent multistage in vitro antiplasmodium activity and in vivo antimalarial efficacy in a humanised mouse model is an inhibitor of multiple Plasmodium falciparum kinases. Blood Plasmodium falciparum Malaria Pennsylvania State University peak area
ST002011 AN003278 The anticancer human mTOR inhibitor MLN0128/Sapanisertib with potent multistage in vitro antiplasmodium activity and in vivo antimalarial efficacy in a humanised mouse model is an inhibitor of multiple Plasmodium falciparum kinases. Blood Plasmodium falciparum Malaria Pennsylvania State University peak area
ST002011 AN003279 The anticancer human mTOR inhibitor MLN0128/Sapanisertib with potent multistage in vitro antiplasmodium activity and in vivo antimalarial efficacy in a humanised mouse model is an inhibitor of multiple Plasmodium falciparum kinases. Blood Plasmodium falciparum Malaria Pennsylvania State University peak area
ST000386 AN000621 Study 2 Investigation of metabolomic blood biomarkers for detection of adenocarcinoma lung cancer (test/validation) Blood Human Cancer University of California, Davis Peak area
ST001232 AN002050 Combining stage - specificity and metabolomic profiling to advance drug discovery for malaria Cultured cells Plasmodium falciparum Malaria Pennsylvania State University Peak area
ST001279 AN002120 K13 mutations driving artemisinin resistance rewrite Plasmodium falciparum’s programmed intra-erythrocytic development and transform mitochondrial physiology Parasite Plasmodium falciparum Malaria Penn State Peak area
ST001384 AN002309 Plasmodium falciparum increased time in circulation underlies persistent asymptomatic infection in the dry season Blood Human Malaria Penn State Peak area
ST002505 AN004127 A Mammalian Conserved Circular RNA CircLARP2 Regulates Hepatocellular Carcinoma Metastasis and Lipid Metabolism (Part 1) Cultured cells Human Cancer University of Science and Technology of China Peak area
ST002499 AN004106 Metabolomics analysis of stress erythroid progenitors (Part 2) Stem cells Mouse Inflammation Pennsylvania State University peak area normalized to IS and cell number
ST001149 AN001896 Plasmodium Niemann-Pick Type C1-Related Protein is a Druggable Target Required for Parasite Membrane Homeostasis Cultured cells Plasmodium falciparum Malaria Pennsylvania State University Peak Area Post-Blank Subtraction
ST002115 AN003513 LC-MS analysis of metabolic changes induced by GPX4 inhibitor treatment in cultured HT1080 cells Cultured cells Human University of Texas MD Anderson Cancer Center Peak area (top)
ST001382 AN002303 Distinct metabolic states of a cell guide alternate fates of mutational buffering through altered proteostasis Bacterial cells E. coli CSIR National Chemical Laboratory Peak intensity
ST001299 AN002163 Metatranscriptomic Analysis of the Mouse Gut Microbiome Response to the Persistent Organic Pollutant 2,3,7,8-Tetrachlorodibenzofuran Intestine Mouse The Pennsylvania State University (Penn State) ppm
ST002805 AN004561 IL-1β-mediated adaptive re-programming of endogenous human cardiac fibroblasts to cells with immune features during fibrotic remodeling Cultured cells Human Pulmonary hypertension Brown University Q3 Peak Area (area under curve)
ST002438 AN003975 Ozone alters glycosphingolipid metabolism and exacerbates characteristics of asthma in mice Lung Mouse Asthma University of California, Davis Relative abundance
ST000930 AN001524 Define alterations in the gut metabolome of mice infected with C. difficile Intestine Mouse North Carolina State University scaled intensity
  logo